MINERVINI, CRESCENZIO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 4.907
EU - Europa 2.250
AS - Asia 1.759
SA - Sud America 423
Continente sconosciuto - Info sul continente non disponibili 257
AF - Africa 108
OC - Oceania 3
Totale 9.707
Nazione #
US - Stati Uniti d'America 4.728
SG - Singapore 682
DE - Germania 602
IT - Italia 584
CN - Cina 406
BR - Brasile 325
RU - Federazione Russa 300
SE - Svezia 191
HK - Hong Kong 177
GB - Regno Unito 159
VN - Vietnam 125
FI - Finlandia 124
FR - Francia 113
CA - Canada 81
BD - Bangladesh 72
IN - India 72
CI - Costa d'Avorio 47
ID - Indonesia 31
MX - Messico 31
ZA - Sudafrica 30
PK - Pakistan 29
AR - Argentina 27
IQ - Iraq 26
UA - Ucraina 24
PL - Polonia 23
BE - Belgio 22
TR - Turchia 22
CO - Colombia 20
VE - Venezuela 18
CZ - Repubblica Ceca 17
PH - Filippine 16
JP - Giappone 15
NL - Olanda 15
CL - Cile 14
CR - Costa Rica 12
AT - Austria 11
ES - Italia 11
IE - Irlanda 10
LT - Lituania 9
MY - Malesia 9
NP - Nepal 9
TN - Tunisia 9
UZ - Uzbekistan 9
SA - Arabia Saudita 8
SV - El Salvador 8
EC - Ecuador 7
GT - Guatemala 7
MA - Marocco 7
NI - Nicaragua 7
HN - Honduras 6
KZ - Kazakistan 6
PE - Perù 6
PS - Palestinian Territory 6
EG - Egitto 5
IL - Israele 5
IR - Iran 5
PT - Portogallo 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
GP - Guadalupe 4
JM - Giamaica 4
LB - Libano 4
PA - Panama 4
RO - Romania 4
RS - Serbia 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
CH - Svizzera 3
CW - ???statistics.table.value.countryCode.CW??? 3
GR - Grecia 3
HR - Croazia 3
KE - Kenya 3
PR - Porto Rico 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
KG - Kirghizistan 2
KR - Corea 2
OM - Oman 2
QA - Qatar 2
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GN - Guinea 1
HT - Haiti 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MQ - Martinica 1
MT - Malta 1
Totale 9.446
Città #
Ashburn 644
Fairfield 451
Singapore 389
San Jose 336
Chandler 310
Woodbridge 254
Houston 208
Seattle 187
Hong Kong 175
Nyköping 164
Cambridge 162
New York 155
Beijing 154
Milan 153
Wilmington 139
Ann Arbor 112
Los Angeles 110
Munich 103
Council Bluffs 90
Helsinki 68
Rome 61
Bari 58
Lauterbourg 53
Falkenstein 48
Abidjan 47
Dallas 45
Jacksonville 44
Boardman 43
Brooklyn 43
Lawrence 43
Roxbury 41
Ho Chi Minh City 36
Nanjing 34
Santa Clara 34
São Paulo 34
Buffalo 29
Turku 27
Columbus 26
Des Moines 26
Moscow 25
Hanoi 23
London 23
Brussels 22
Jakarta 22
Marseille 22
Phoenix 22
Denver 21
Frankfurt am Main 21
Montreal 21
Redwood City 21
Warsaw 20
Atlanta 19
Chicago 19
Johannesburg 19
Naples 19
Falls Church 18
Toronto 18
Nanchang 16
Paris 16
Princeton 16
San Diego 16
Chennai 15
Inglewood 15
Orem 15
Rio de Janeiro 15
Guangzhou 14
Tokyo 14
Dong Ket 13
Nuremberg 13
Poplar 12
Changsha 11
Mexico City 11
San José 11
Shanghai 11
Boston 10
Brasília 10
Dhaka 10
Figino 10
Lahore 10
Brno 9
New Delhi 9
San Francisco 9
Tashkent 9
Baghdad 8
Dublin 8
Düsseldorf 8
Hebei 8
Manchester 8
Santiago 8
Bogotá 7
Florence 7
Managua 7
Palermo 7
Porto Alegre 7
Portsmouth 7
The Dalles 7
Turin 7
Amsterdam 6
Belo Horizonte 6
Dearborn 6
Totale 5.953
Nome #
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 263
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 258
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 230
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 229
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 221
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 221
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 220
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 211
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 208
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 207
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 203
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 202
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 201
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 198
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 195
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 189
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 188
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 182
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 173
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 170
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 169
Altered gene expression encoding cytochines, grow factors and cell cycle regulators in the endometrium of women with chronic endometritis 168
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 167
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 164
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 159
MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene 158
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 158
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 154
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 150
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? 149
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 149
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 146
Identification of novel LTR retrotransposons in the genome of Aedes aegypti 142
A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome 142
Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph plus Acute Lymphoblastic Leukemia 138
Factors Affecting the Quality of Bacterial Genomes Assemblies by Canu after Nanopore Sequencing 135
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia 130
Epitranscriptomics in normal and malignant hematopoiesis 124
Identification and Characterisation of pST1023 A Mosaic, Multidrug-Resistant and Mobilisable IncR Plasmid 116
Evidence of the physical interaction between rpl22 and the transposable element doc5, a heterochromatic transposon of drosophila melanogaster 116
null 115
Genome characterization and CRISPR-Cas9 editing of a human neocentromere 113
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis 109
Nanopore targeted sequencing for rapid gene mutations detection in acute myeloid leukemia 107
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater? 106
JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander? 105
Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements 104
Nanopore sequencing sheds a light on the FLT3 gene mutations complexity in acute promyelocytic leukemia 104
TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition? 102
Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation. 99
Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event 98
Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities 97
The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms 95
null 95
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms 95
Heterochromatin protein 1 interacts with 5′UTR of transposable element ZAM in a sequence-specific fashion 95
The Ribosomal Protein RpL22 Interacts In Vitro with 5′-UTR Sequences Found in Some Drosophila melanogaster Transposons 94
Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement 90
IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective 88
null 87
IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative neoplasms 80
The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis 73
null 73
Systemic Mastocytosis With Associated Chronic Lymphocytic Leukemia: A Matter Of Diseases Or Prognostic Factors 72
Third-Generation Sequencing in Clinical Practice: The New Era of Precision Medicine? 67
Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant? 62
null 58
Splenomegaly in de novo acute myeloid leukemia is associated with ASXL1 mutations together with a distinct clinical and gene expression profile 41
null 29
Chimeric Antigen Receptor-T Cells Fate after Infusion: Cellular Kinetics and Molecular Monitoring 20
RUNX1A isoform is overexpressed in acute myeloid leukemia and is associated with FLT3 internal tandem duplications 19
One Grammar, Many Labels: Revisiting the Continuum of Myeloid Neoplasms 12
Totale 9.707
Categoria #
all - tutte 37.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022322 0 0 0 0 14 38 18 37 34 33 59 89
2022/2023752 74 123 48 54 89 94 14 88 125 7 14 22
2023/2024419 26 51 20 29 42 147 10 15 0 15 11 53
2024/20251.422 85 19 62 89 70 96 218 151 30 112 194 296
2025/20263.321 441 125 207 412 497 177 290 81 381 315 102 293
2026/2027778 83 139 159 385 12 0 0 0 0 0 0 0
Totale 9.707